[{"path":"https://mrc-ide.github.io/epireview/articles/pathogen_marburg.html","id":"outbreaks","dir":"Articles","previous_headings":"","what":"Outbreaks","title":"Marburg Virus Disease (MVD)","text":"Country Location Article Start End Deaths Confirmed Suspected Asymptomatic Severe/hospitalised Confirmation Method Angola  Carroll 2013 2005 2005 227 252   0 specified Angola  Palvin 2014 2004 2005 227 252     Angola Uige Province Towner 2006 Oct 2004 Jul 2005 227 252   0  Democratic Republic Congo Durba Watsa Borchert 2002 Oct 1998 May 1999 61 73   0 Symptoms Democratic Republic Congo Durba Watsa Bausch 2006 Oct 1998 Sep 2000 125 48 106  0 Molecular Democratic Republic Congo Durba Watsa villages Borchert 2006 Oct 1998 Aug 2000  76 33 0  Molecular Democratic Republic Congo  Palvin 2014 1998 2000 128 154     Germany Marburg, Frankfurt Main Albarino 2013 18 Aug 1968 13 Nov 1968 5 23  1  Symptoms Germany, Yugoslavia Marburg (23), Frankfurt Main (6), Belgrade (2) Martini 1973 Aug 1968 Nov 1968 7 31  1  Symptoms Germany, Yugoslavia  Pavlin 2014 1967  7 31     Kenya  Pavlin 2014 1980  1 2     Kenya  Pavlin 2014 1987  1 1     Netherlands  Pavlin 2014 2008  1 1     Russian Federation  Pavlin 2014 1988  1 1     Russian Federation  Pavlin 2014 1990  0 1     South Africa, Zimbabwe Johannesburg Conrad 1978 12 Feb 1975  1 3   1 Molecular Uganda Kamwenge Ibanda Adjemian 2011 10 Jun 2007 14 Sep 2007 1 4   0 Molecular Uganda Kabale; Ibanda; Mbarara; Kampala Albarino 2013 18 Oct 2012 7 Nov 2012 4 15    Molecular Uganda Ibanda, Kabale Kamwenge Districts Knust 2015 Jul 2012 10 Nov 2012 15 15 11   Molecular Uganda Ibanda Kabale Mbonye 2012 Sep 2012 13 Nov 2012 7 9 5   Molecular Uganda Kampala Nyakarahuka 2017 17 Sep 2014 28 Sep 2014 1 1   1 Molecular Uganda  Pavlin 2014 2007  2 4     United States Colorado Pavlin 2014 2008  0 1","code":""},{"path":[]},{"path":[]},{"path":"https://mrc-ide.github.io/epireview/articles/pathogen_marburg.html","id":"severity","dir":"Articles","previous_headings":"Parameters","what":"Severity","title":"Marburg Virus Disease (MVD)","text":"Naive CFRs computed outbreak data","code":""},{"path":"https://mrc-ide.github.io/epireview/articles/pathogen_marburg.html","id":"delays","dir":"Articles","previous_headings":"Parameters","what":"Delays","title":"Marburg Virus Disease (MVD)","text":"Article Country Parameter type Survey year Delays (days) Statistic Uncertainty Uncertainty type Population Group Timing survey Outcome Ajelli 2012 Angola Generation Time Mar-Nov 2005 9.0 Mean 8.2, 10 CI95% General population Mid outbreak  Ajelli 2012 Angola Generation Time Mar-Nov 2005 5.4 Standard Deviation 3.9, 8.6 CI95% General population Mid outbreak  Ajelli 2012 Angola Generation Time Mar-Nov 2005 9.3 Mean 3.7, 14.6 CI95% General population Mid outbreak  Martini 1973 Germany, Yugoslavia Incubation Period Aug-Nov 1968   04-Jul Range    Gear 1975 South Africa Incubation Period Feb-75   07-Aug Range Healthcare workers Mid outbreak  Knust 2015 Uganda Time Care 2012 14.3 Mean Apr-22 Range General population Post outbreak Bausch 2006 Democratic Republic Congo Time Symptom Careseeking 1999-2000 4.5 Median 0 - 24 Range Mid outbreak  Gear 1975 South Africa Time Symptom Careseeking Feb-75 4.0   Start outbreak  Knust 2015 Uganda Time Symptom Careseeking 2012 4.0 Mean   General population   Ajelli 2012 Angola Time Symptom Outcome Mar-Nov 2005 7.0 Median 05-Sep Range General population Mid outbreak Death Ajelli 2012 Angola Time Symptom Outcome Mar-Nov 2005 9.0 Median 0 - 56 Range General population Mid outbreak Death Gear 1975 South Africa Time Symptom Outcome Feb-75 9.0    Start outbreak Knust 2015 Uganda Time Symptom Outcome 2012 9.0 Mean 6.5 - 9 Range General population Post outbreak Death Knust 2015 Uganda Time Symptom Outcome 2012 22.0 Mean 16 - 30 Range General population  ","code":""},{"path":"https://mrc-ide.github.io/epireview/articles/pathogen_marburg.html","id":"seroprevalence","dir":"Articles","previous_headings":"Parameters","what":"Seroprevalence","title":"Marburg Virus Disease (MVD)","text":"Article Country Parameter type* Survey year Seroprevalence (%) Uncertainty (%) Uncertainty type Number Seropositive Sample size Population Group Timing survey Disaggregated dataavailable Gonzalez 2000 Central African Republic IgG Nov-95 2.40 0 - 5.6 Range 33 1,340    Johnson 1993 Central African Republic IFA     3 427 Outdoor workers   Johnson 1993 Central African Republic IFA  3.20 1 - 7.4 Range 137 4,295 General population Pre outbreak Age, Region, Sex Borchert 2007 Democratic Republic Congo IgG 2001-2002 2.10     Healthcare workers Post outbreak  Bausch 2003 Democratic Republic Congo IgG May-99 2.00   15 912  Mid outbreak  Borchert 2005 Democratic Republic Congo IFA  0.00 0 - 1.2 Range 0 300  Post outbreak  Borchert 2006 Democratic Republic Congo IgG  1.65 0.2, 5.8 CI95%   Household contacts survivors Post outbreak  Ivanoff 1982 Gabon IFA Feb-Mar 1980 0.00   0 197    Ivanoff 1982 Gabon IFA Feb-Mar 1980 0.00   0 28 Pregnant women   Ivanoff 1982 Gabon IFA Feb-Mar 1980 0.00   0 28   Becker 1992 Germany IgG  2.60       Johnson 1983 Kenya IFA 1980-1981 0.00   0 741 General population Post outbreak  Johnson 1983 Kenya IFA     8 1,899   Region Martini 1973 Kenya Unspecified     0 79 Post outbreak  Smith 1982 Kenya Unspecified     2 186 Persons investigation Post outbreak  Smith 1982 Kenya Unspecified     3 100 Healthcare workers Post outbreak  Smith 1982 Kenya Unspecified     0 224 General population Post outbreak  Smith 1982 Kenya Unspecified     0 63 Post outbreak  Smith 1982 Kenya Unspecified     0 79 Post outbreak  Smith 1982 Kenya Unspecified     0 44 Outdoor workers Post outbreak  Van der Waals 1986 Liberia IFA 1981-1982 1.30   3 225 , Region Mathiot 1989 Madagascar Unspecified  0.00   0 381  Region Tomori 1988 Nigeria IFA  1.70   29 1,677 General population   Moyen 2015 Republic Congo IgG Mar-Jul 2011 0.50      Pre outbreak  Schoepp 2014 Sierra Leone IgM 2006-2008 3.60     Persons investigation  Rugarabamu 2022 Tanzania IgM Jun-Nov 2018 0.30   1 308  Region Evans 2018 Uganda IgG Mar-Jul 2013    0 331   Rodhain 1989 Uganda HAI/HI May-84 4.50   6 132    Gonzalez 1989 Cameroon, Central African Republic, Chad, Republic Congo, Equatorial Guinea, Gabon Unspecified 1985-1987 0.39   20 5,070 General population  Region *HAI/HI: Hemagglutination Inhibition Assay; IFA: Indirect Fluorescent Antibody assay; IgG: Immunoglobulin G; IgM: Immunoglobulin M; Unspecified assay.","code":""},{"path":[]},{"path":"https://mrc-ide.github.io/epireview/articles/pathogen_marburg.html","id":"risk-factors","dir":"Articles","previous_headings":"","what":"Risk Factors","title":"Marburg Virus Disease (MVD)","text":"Article Country Survey year Outcome Risk factor  Significant Adjusted Sample size Population sample type Population group Timing survey Borchert 2005 Angola Mar-Jul 2005 Infection Household contact  Significant Unknown 102 Hospital based Persons investigation Mid outbreak Borchert 2005 Angola Mar-Jul 2005 Infection  Significant Unknown 102 Hospital based Persons investigation Mid outbreak Borchert 2005 Angola Mar-Jul 2005 Infection Gathering  Significant Unknown 102 Hospital based Persons investigation Mid outbreak Borchert 2005 Angola Mar-Jul 2005 Infection Occupation - Funeral burial services  Significant Unknown 102 Hospital based Persons investigation Mid outbreak Knust 2015 Uganda 2012 Infection Gathering  Significant Unknown 26 Community based General population Post outbreak Knust 2015 Uganda 2012 Infection  significant Unknown 26 Community based General population Post outbreak Knust 2015 Uganda 2012 Infection Sex  significant Unknown 26 Community based General population Post outbreak Amman 2012 Uganda  Infection Contact animal  Significant Unknown     Amman 2012 Uganda  Infection  Significant Unknown     Bausch 2003 Democratic Republic Congo May-99 Serology Contact animal  significant Adjusted 912 Population based   Bausch 2003 Democratic Republic Congo May-99 Serology Household contact  significant Adjusted 912 Population based   Bausch 2003 Democratic Republic Congo May-99 Serology Occupation - Funeral burial services  significant Adjusted 912 Population based   Bausch 2003 Democratic Republic Congo May-99 Serology Hospitalisation  Significant Adjusted 915 Population based   Borchert 2005 Democratic Republic Congo  Serology Contact animal  significant Unknown 300 Community based  Post outbreak Borchert 2005 Democratic Republic Congo  Serology Gathering  significant Unknown 300 Community based  Post outbreak","code":""},{"path":[]},{"path":"https://mrc-ide.github.io/epireview/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Rebecca Nash. Author, maintainer. Christian Morgenstern. Author. Gina Cuomo-Dannenburg. Contributor. Ruth McCabe. Contributor. Kelly McCain. Contributor.","code":""},{"path":"https://mrc-ide.github.io/epireview/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Nash R, Morgenstern C (2023). epireview: Tools update summarise latest pathogen data Pathogen Epidemiology Review Group (PERG). R package version 0.0.0.9000, https://mrc-ide.github.io/epireview/.","code":"@Manual{,   title = {epireview: Tools to update and summarise the latest pathogen data from the Pathogen Epidemiology Review Group (PERG)},   author = {Rebecca Nash and Christian Morgenstern},   year = {2023},   note = {R package version 0.0.0.9000},   url = {https://mrc-ide.github.io/epireview/}, }"},{"path":"https://mrc-ide.github.io/epireview/index.html","id":"epireview","dir":"","previous_headings":"","what":"Tools to update and summarise the latest pathogen data from the Pathogen Epidemiology Review Group (PERG)","title":"Tools to update and summarise the latest pathogen data from the Pathogen Epidemiology Review Group (PERG)","text":"epireview tool obtain latest data Pathogen Epidemiology Review Group (PERG) contains tools update data new, peer-reviewed papers existing pathogens database add entirely new pathogens. install latest version, use:","code":"devtools::install_github(\"mrc-ide/epireview\", build_vignettes = TRUE)"},{"path":"https://mrc-ide.github.io/epireview/index.html","id":"project-overview","dir":"","previous_headings":"","what":"Project overview","title":"Tools to update and summarise the latest pathogen data from the Pathogen Epidemiology Review Group (PERG)","text":"COVID-19 pandemic highlighted critical role mathematical modelling can play supporting evidence-based decision-making outbreaks (e.g. project expected epidemic size, required hospital capacity assess potential population-level impact interventions). However, early epidemic, modelling efforts can hampered delayed lack centralised resource summarising existing model structures input parameters disease interest. Literature reviews therefore often conducted epidemics identify plausible parameter ranges /existing mathematical model structures (e.g. Van Kerkhove et al. Scientific data 2015) mostly limited individual parameters. propose literature reviews best conducted advance next epidemic comprehensive across relevant transmission modelling parameters, results stored dynamic database updated new information becomes available. streamline real-time modelling pipelines turn enable rapid generation evidence support timely decision making. group ~20 volunteer researchers currently formerly Imperial College London interest outbreaks working together systematically review mathematical models parameters nine World Health Organization () 2019 blue-print priority pathogens: Nairo virus (Crimean-Congo haemorrhagic fever), Ebola virus, Henipa virus, Lassa mammarenavirus, Marburg virus, Middle East respiratory syndrome coronavirus (MERS-CoV), Rift Valley fever virus, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-1), Zika virus. pathogens, strains thereof, approved vaccines treatments hence anticipate mathematical modelling likely play major role supporting epidemic response. include SARS-CoV-2 vaccines exist pathogen body literature far exceeds capacity team. pathogen, review published mathematical models, information transmission, evolution, natural history severity, well seroprevalence studies reported sizes previous outbreaks (see Table 1). quality paper also assessed part review.","code":""},{"path":"https://mrc-ide.github.io/epireview/index.html","id":"pathogen-database","dir":"","previous_headings":"","what":"Pathogen database","title":"Tools to update and summarise the latest pathogen data from the Pathogen Epidemiology Review Group (PERG)","text":"One output project database initially populated information extracted can easily updated new parameter estimates information additional pathogens become available. collaboration , data stored central, open access, repository ensuring can useful resource global infectious disease epidemiology modelling community. addition, write series 11 papers including one overview paper comparing pathogens, one paper priority pathogen describing pathogen specific characteristics, paper reporting guidelines quality assessment. work fill two knowledge gaps. First, provide --date comprehensive picture pathogen-specific knowledge understanding disease transmission mechanisms, background levels immunity, previously modelled interventions, characteristics affecting risk infection severe outcome, used target resources effectively. Second, systematic review intends collate necessary information effective real-time epidemic modelling. code repository provides functions access data pathogen. update repository progress work. expected timeline provided table. provide functionality update existing databases new data new research (line inclusion exclusion criteria) becomes available. Tables figures pathogen can updated new data added database. Vignettes github wiki contain required information data. add functionality create/add new pathogens currently included review.","code":""},{"path":[]},{"path":"https://mrc-ide.github.io/epireview/reference/load_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Load data for a particular pathogen — load_data","title":"Load data for a particular pathogen — load_data","text":"Load data particular pathogen","code":""},{"path":"https://mrc-ide.github.io/epireview/reference/load_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Load data for a particular pathogen — load_data","text":"","code":"load_data(table_type = NA, pathogen = NA)"},{"path":"https://mrc-ide.github.io/epireview/reference/load_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Load data for a particular pathogen — load_data","text":"table_type type table (either article, parameter, outbreak, model) loaded pathogen name pathogen","code":""},{"path":"https://mrc-ide.github.io/epireview/reference/load_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Load data for a particular pathogen — load_data","text":"return data table_type pathogen","code":""},{"path":"https://mrc-ide.github.io/epireview/reference/load_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Load data for a particular pathogen — load_data","text":"","code":"load_data(\"outbreak\",\"marburg\") #> Rows: 23 Columns: 20 #> ── Column specification ──────────────────────────────────────────────────────── #> Delimiter: \",\" #> chr  (5): outbreak_start_month, outbreak_end_month, outbreak_country, outbre... #> dbl (13): outbreak_id, article_id, outbreak_start_day, outbreak_start_year, ... #> lgl  (2): outbreak_size, asymptomatic_transmission #>  #> ℹ Use `spec()` to retrieve the full column specification for this data. #> ℹ Specify the column types or set `show_col_types = FALSE` to quiet this message. #> # A tibble: 23 × 20 #>    outbreak_id article_id outbreak_start_day outbreak_start_month #>          <dbl>      <dbl>              <dbl> <chr>                #>  1           4         20                 NA Aug                  #>  2           5         23                 18 Aug                  #>  3           6         23                 18 Oct                  #>  4           7         21                 NA Oct                  #>  5          10         33                 NA NA                   #>  6          12         42                 NA Jul                  #>  7          13         45                 NA Oct                  #>  8          14         49                 10 Jun                  #>  9          17         57                 NA Oct                  #> 10          19         60                 12 Feb                  #> # ℹ 13 more rows #> # ℹ 16 more variables: outbreak_start_year <dbl>, outbreak_end_day <dbl>, #> #   outbreak_end_month <chr>, outbreak_date_year <dbl>, #> #   outbreak_duration_months <dbl>, outbreak_size <lgl>, #> #   asymptomatic_transmission <lgl>, outbreak_country <chr>, #> #   outbreak_location <chr>, cases_confirmed <dbl>, cases_mode_detection <chr>, #> #   cases_suspected <dbl>, cases_asymptomatic <dbl>, deaths <dbl>, …"},{"path":"https://mrc-ide.github.io/epireview/reference/quality_assessment_plots.html","id":null,"dir":"Reference","previous_headings":"","what":"Plots for the quality assessment of the included studies — quality_assessment_plots","title":"Plots for the quality assessment of the included studies — quality_assessment_plots","text":"Plots quality assessment included studies","code":""},{"path":"https://mrc-ide.github.io/epireview/reference/quality_assessment_plots.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plots for the quality assessment of the included studies — quality_assessment_plots","text":"","code":"quality_assessment_plots(pathogen = NA)"},{"path":"https://mrc-ide.github.io/epireview/reference/quality_assessment_plots.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plots for the quality assessment of the included studies — quality_assessment_plots","text":"pathogen pathogen data set consider","code":""},{"path":"https://mrc-ide.github.io/epireview/reference/quality_assessment_plots.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plots for the quality assessment of the included studies — quality_assessment_plots","text":"two plots quality assessment","code":""},{"path":"https://mrc-ide.github.io/epireview/reference/quality_assessment_plots.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Plots for the quality assessment of the included studies — quality_assessment_plots","text":"","code":"quality_assessment_plots(pathogen = \"marburg\") #> Rows: 58 Columns: 24 #> ── Column specification ──────────────────────────────────────────────────────── #> Delimiter: \",\" #> chr  (7): pathogen, first_author_first_name, article_title, doi, journal, no... #> dbl (16): article_id, covidence_id, year_publication, volume, issue, page_fi... #> lgl  (1): paper_copy_only #>  #> ℹ Use `spec()` to retrieve the full column specification for this data. #> ℹ Specify the column types or set `show_col_types = FALSE` to quiet this message. #> `geom_smooth()` using method = 'loess' and formula = 'y ~ x' #> Warning: Removed 2 rows containing non-finite values (`stat_smooth()`). #> Warning: Removed 2 rows containing missing values (`geom_point()`)."}]
